Annual Report 2004
| PDF, 3503 kb
|
Key Figures
| PDF, 28 kb
|
Management Board of MorphoSys AG
| PDF, 72 kb
|
Letter to the Shareholders
| PDF, 49 kb
|
Market & Strategy
|
PDF, 112 kb
|
Magazine: Doing Business with Antibodies
| PDF, 717 kb
|
Research & Development
|
PDF, 102 kb
|
Interview with Mr. Makoto Ogasawara (GeneFrontier Corp.)
| PDF, 172 kb
|
The MorphoSys Share
| PDF, 122 kb
|
Management Report
| PDF, 146 kb
|
Financial Statements (IFRS) and Notes
|
PDF, 248 kb
|
Audit Opinion
|
PDF, 26 kb
|
Financial Statements (IFRS) and Notes
| PDF, 37 kb
|
Statements of Operations U.S. GAAP
|
PDF, 34 kb
|
Balance Sheet in Accordance with German GAAP
|
PDF, 41 kb
|
Profit and Loss Statement in Accordance with German GAAP
|
PDF, 48 kb
|
Declaration of Conformity
|
PDF, 31 kb
|
Corporate Governance and Remuneration Report
|
PDF, 68 kb
|
Supervisory Board Report
|
PDF, 39 kb
|
Supervisory Board of MorphoSys AG
|
PDF, 112 kb
|
